These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. The use of fondaparinux and rituximab for recurrent thrombotic events in antiphospholipid syndrome. Sayar Z; Burke S; Mittal P; Cohen H Lupus; 2022 Oct; 31(12):1485-1490. PubMed ID: 36074077 [TBL] [Abstract][Full Text] [Related]
7. Use of direct oral anticoagulants in antiphospholipid syndrome. Cohen H; Efthymiou M; Isenberg DA J Thromb Haemost; 2018 Jun; 16(6):1028-1039. PubMed ID: 29624847 [TBL] [Abstract][Full Text] [Related]
8. Thrombotic risk in the antiphospholipid syndrome. Lim W Semin Thromb Hemost; 2014 Oct; 40(7):741-6. PubMed ID: 25299926 [TBL] [Abstract][Full Text] [Related]
9. Antiphospholipid syndrome - an update. Linnemann B Vasa; 2018 Oct; 47(6):451-464. PubMed ID: 30205764 [TBL] [Abstract][Full Text] [Related]
10. Diagnostics and treatment of thrombotic antiphospholipid syndrome (APS): A personal perspective. Pengo V; Denas G Thromb Res; 2018 Sep; 169():35-40. PubMed ID: 30007134 [TBL] [Abstract][Full Text] [Related]
11. The antiphospholipid syndrome: still an enigma. Chaturvedi S; McCrae KR Hematology Am Soc Hematol Educ Program; 2015; 2015():53-60. PubMed ID: 26637701 [TBL] [Abstract][Full Text] [Related]
12. Thrombotic Antiphospholipid Syndrome and Direct Oral Anticoagulants: Unmet Needs and Review of the Literature. Marco-Rico A; Marco-Vera P Semin Thromb Hemost; 2023 Oct; 49(7):736-743. PubMed ID: 36996874 [TBL] [Abstract][Full Text] [Related]
13. Clinical characteristics and thrombosis outcomes of paediatric antiphospholipid syndrome: analysis of 58 patients. Ma J; Song H; Wei M; He Y Clin Rheumatol; 2018 May; 37(5):1295-1303. PubMed ID: 28748509 [TBL] [Abstract][Full Text] [Related]
14. Can we withdraw anticoagulation in patients with antiphospholipid syndrome after seroconvertion? Sciascia S; Coloma-Bazán E; Radin M; Bertolaccini ML; López-Pedrera C; Espinosa G; Meroni PL; Cervera R; Cuadrado MJ Autoimmun Rev; 2017 Nov; 16(11):1109-1114. PubMed ID: 28899804 [TBL] [Abstract][Full Text] [Related]
15. EULAR recommendations for the management of antiphospholipid syndrome in adults. Tektonidou MG; Andreoli L; Limper M; Amoura Z; Cervera R; Costedoat-Chalumeau N; Cuadrado MJ; Dörner T; Ferrer-Oliveras R; Hambly K; Khamashta MA; King J; Marchiori F; Meroni PL; Mosca M; Pengo V; Raio L; Ruiz-Irastorza G; Shoenfeld Y; Stojanovich L; Svenungsson E; Wahl D; Tincani A; Ward MM Ann Rheum Dis; 2019 Oct; 78(10):1296-1304. PubMed ID: 31092409 [TBL] [Abstract][Full Text] [Related]
16. Thrombotic Management of Antiphospholipid Syndrome: Towards Novel Targeted Therapies. Islam MA; Alam F; Wong KK; Kamal MA; Gan SH Curr Vasc Pharmacol; 2017; 15(4):313-326. PubMed ID: 28056758 [TBL] [Abstract][Full Text] [Related]
17. Recognition and management of antiphospholipid syndrome. Gerosa M; Meroni PL; Erkan D Curr Opin Rheumatol; 2016 Jan; 28(1):51-9. PubMed ID: 26599382 [TBL] [Abstract][Full Text] [Related]
18. [Seronegative antiphospholipid syndrome, catastrophic syndrome, new anticoagulants: learning from a difficult case report]. Joalland F; de Boysson H; Darnige L; Johnson A; Jeanjean C; Cheze S; Augustin A; Auzary C; Geffray L Rev Med Interne; 2014 Nov; 35(11):752-6. PubMed ID: 25217794 [TBL] [Abstract][Full Text] [Related]
19. 14th International Congress on Antiphospholipid Antibodies: task force report on antiphospholipid syndrome treatment trends. Erkan D; Aguiar CL; Andrade D; Cohen H; Cuadrado MJ; Danowski A; Levy RA; Ortel TL; Rahman A; Salmon JE; Tektonidou MG; Willis R; Lockshin MD Autoimmun Rev; 2014 Jun; 13(6):685-96. PubMed ID: 24468415 [TBL] [Abstract][Full Text] [Related]
20. The antiphospholipid syndrome: from pathophysiology to treatment. Negrini S; Pappalardo F; Murdaca G; Indiveri F; Puppo F Clin Exp Med; 2017 Aug; 17(3):257-267. PubMed ID: 27334977 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]